L
Loreto Martínez-González
Researcher at Spanish National Research Council
Publications - 22
Citations - 346
Loreto Martínez-González is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Amyotrophic lateral sclerosis & Kinase. The author has an hindex of 8, co-authored 20 publications receiving 191 citations.
Papers
More filters
Journal ArticleDOI
Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors
Annachiara Gandini,Annachiara Gandini,Manuela Bartolini,Daniele Tedesco,Loreto Martínez-González,Carlos Roca,Nuria E. Campillo,Josefa Zaldivar-Diez,Concepción Pérez,Giampaolo Zuccheri,Giampaolo Zuccheri,Andrea Miti,Andrea Miti,Alessandra Feoli,Sabrina Castellano,Sabrina Petralla,Barbara Monti,Martina Rossi,Fabio Moda,Giuseppe Legname,Ana Martínez,Maria Laura Bolognesi +21 more
TL;DR: The discovery of 2,4-thiazolidinedione derivatives endowed with a suitable cellular safety profile are reported on, believed to be the first balanced, nontoxic, dual-acting compounds hitting tau cascade at two different hubs.
Journal ArticleDOI
Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment
Loreto Martínez-González,Carmen Rodríguez-Cueto,Diego Cabezudo,Fernando Bartolomé,Pol Andrés-Benito,Pol Andrés-Benito,Isidro Ferrer,Isidro Ferrer,Carmen Gil,Ángeles Martín-Requero,Javier Fernández-Ruiz,Ana Martínez,Eva de Lago +12 more
TL;DR: Data show for the first time the in vivo modulation of TDP-43 toxicity by CK-1δ inhibition with IGS-2.7, which may explain the benefits in the preservation of spinal motor neurons and point to the relevance of CK- 1δ inhibitors in a future disease-modifying treatment for ALS.
Journal ArticleDOI
Development of Blood-Brain Barrier Permeable Nitrocatechol-Based Catechol O-Methyltransferase Inhibitors with Reduced Potential for Hepatotoxicity.
Tiago H. Silva,Tarek Mohamed,Arash Shakeri,Praveen P.N. Rao,Loreto Martínez-González,Daniel I. Perez,Ana Martínez,Maria João Valente,Jorge Garrido,Eugenio Uriarte,Paula Serrão,Patrício Soares-da-Silva,Fernando Remião,Fernanda Borges +13 more
TL;DR: New nitrocatechol COMT inhibitors based on naturally occurring caffeic acid and caffeic Acid phenethyl ester displayed potent inhibition of peripheral and cerebral COMT within the nanomolar range and confirmed that the major interactions with COMT were established via the nitrocamine ring.
Journal ArticleDOI
Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.
Alicia Mansilla,Antonio Chaves-Sanjuan,Nuria E. Campillo,Ourania Semelidou,Loreto Martínez-González,Lourdes Infantes,Juana María González-Rubio,Carmen Gil,Santiago Conde,Efthimios M. C. Skoulakis,Alberto Ferrús,Ana Martínez,María José Sánchez-Barrena +12 more
TL;DR: A small molecule, the phenothiazine FD44, is identified that binds the interaction surface between NCS-1 and Ric8a, preventing the formation of the complex, and it restores normal synapse number and associative learning in a Drosophila FXS model.
Journal ArticleDOI
Novel Curcumin-Diethyl Fumarate Hybrid as a dualistic GSK-3β inhibitor/Nrf2 inducer for the treatment of Parkinson’s disease
Rita Maria Concetta Di Martino,Letizia Pruccoli,Alessandra Bisi,Silvia Gobbi,Angela Rampa,Ana Martínez,Concepción Pérez,Loreto Martínez-González,Maria Paglione,Elia Di Schiavi,Francesca Seghetti,Andrea Tarozzi,Federica Belluti +12 more
TL;DR: In this article, a dual GSK-3β inhibitor/Nrf2 inducer was designed to increase the neuronal resistance to oxidative stress and neuroinflammation in a C. elegans model.